Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Total transaction value of the divestment is Rs. 3,660 million
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Subscribe To Our Newsletter & Stay Updated